(Q45924298)

English

Overexpression of PTK6 (breast tumor kinase) protein--a prognostic factor for long-term breast cancer survival--is not due to gene amplification.

scientific article published on 21 July 2009

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19621240

Overexpression of PTK6 (breast tumor kinase) protein--a prognostic factor for long-term breast cancer survival--is not due to gene amplification. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19621240

1 reference

based on heuristic

inferred from title

breast neoplasm

1 reference

based on heuristic

inferred from title

Michael J Atkinson

6

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19621240

7

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19621240

Herbert Braselmann

object named as

Herbert Braselmann

3

0 references

author name string

Michaela Aubele

1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19621240

Sanja Vidojkovic

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19621240

Dominique Ritterswürden

4

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19621240

Gert Auer

5

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19621240

Heinz Höfler

8

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19621240

Sandra Rauser

9

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19621240

John M S Bartlett

10

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19621240

publication date

21 July 2009

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19621240

Virchows Archiv

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19621240

455

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19621240

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19621240

117-123

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19621240

Impact of polysomy 17 on HER-2/neu immunohistochemistry in breast carcinomas without HER-2/neu gene amplification

1 reference

https://api.crossref.org/works/10.1007%2FS00428-009-0809-8

21 January 2018

Amplification of oncogenes revisited: from expression profiling to clinical application

1 reference

https://pubmed.ncbi.nlm.nih.gov/19621240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amplification of oncogenes in human cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19621240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19621240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression profile of tyrosine kinases in breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19621240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential expression of the non-receptor tyrosine kinase BRK in oral squamous cell carcinoma and normal oral epithelium.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19621240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alterations of the CCND1 and HER-2/neu (ERBB2) proteins in esophageal and gastric cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/19621240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

No amplifications of hypoxia-inducible factor-1alpha gene in invasive breast cancer: a tissue microarray study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19621240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simultaneous over-expression of the Her2/neu and PTK6 tyrosine kinases in archival invasive ductal breast carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/19621240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

c-erbB-2 positivity is a factor for poor prognosis in breast cancer and poor response to hormonal or chemotherapy treatment in advanced disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19621240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19621240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cloning and characterisation of cDNAs encoding a novel non-receptor tyrosine kinase, brk, expressed in human breast tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/19621240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of chromosome 17 polysomy on HER-2/neu status in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19621240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rules for making human tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19621240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Altered localization and activity of the intracellular tyrosine kinase BRK/Sik in prostate tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19621240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulated association of protein kinase B/Akt with breast tumor kinase

1 reference

https://pubmed.ncbi.nlm.nih.gov/19621240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sequential multilocus fluorescence in situ hybridization can detect complex patterns of increased gene dosage at the single cell level in tissue sections

1 reference

https://pubmed.ncbi.nlm.nih.gov/19621240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic relevance of gene amplifications and coamplifications in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19621240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of RNA interference to validate Brk as a novel therapeutic target in breast cancer: Brk promotes breast carcinoma cell proliferation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19621240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of the BRK tyrosine kinase in mammary epithelial cells enhances the coupling of EGF signalling to PI 3-kinase and Akt, via erbB3 phosphorylation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19621240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

No strong association between HER-2/neu protein overexpression and gene amplification in high-grade invasive urothelial carcinomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19621240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19621240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BRK tyrosine kinase expression in a high proportion of human breast carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/19621240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeting HER proteins in cancer therapy and the role of the non-target HER3.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19621240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BRK/Sik expression in the gastrointestinal tract and in colon tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/19621240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

1 reference

https://pubmed.ncbi.nlm.nih.gov/19621240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Can molecular markers predict when to implement treatment with aromatase inhibitors in invasive breast cancer?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19621240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of the type I growth factor receptors in a large series of human primary breast cancers quantified with a real-time reverse transcription-polymerase chain reaction assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/19621240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The BRK tyrosine kinase is expressed in high-grade serous carcinoma of the ovary

1 reference

https://pubmed.ncbi.nlm.nih.gov/19621240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The nuclear tyrosine kinase BRK/Sik phosphorylates and inhibits the RNA-binding activities of the Sam68-like mammalian proteins SLM-1 and SLM-2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19621240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The upgraded role of HER3 and HER4 receptors in breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19621240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluorescence in situ hybridization evaluation of c-erbB-2 gene amplification and chromosomal anomalies in bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19621240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated expression levels of NCOA3, TOP1, and TFAP2C in breast tumors as predictors of poor prognosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19621240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of cIAP1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19621240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies of the HER-2/neu proto-oncogene in human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19621240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00428-009-0809-8

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19621240

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19621240

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45924298&oldid=2207460267"